November 2022 Editor's choice

Editorial

Peter Tugwell et al. J Clin Epidemiol. 2022 Nov.

. 2022 Nov:151:A1-A2.

doi: 10.1016/j.jclinepi.2022.11.013.

No abstract available

Comment on

Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END).
McCaul M, Tovey D, Young T, Welch V, Dewidar O, Goetghebeur M, Kredo T, Tricco AC, Glover RE, Tufte J, Qaseem A, Ludovic R, Morgan RL, Vandvik PO, Florez ID; COVID-END Recommending, Synthesizing and Equity Working Groups. McCaul M, et al. J Clin Epidemiol. 2022 Nov;151:88-95. doi: 10.1016/j.jclinepi.2022.07.008. Epub 2022 Jul 19. J Clin Epidemiol. 2022. PMID: 35868494 Free PMC article.

1. Dewidar O, Kawala B., Antequera A et al. Methodological guidance for incorporating equity when informing rapid policy and guidelines development. J Clin Epidemiol, 150, p142-p153 - PMC - PubMed
1. Stewart R., Boutron I., Akl E.A. The Global Evidence Commission’s Report provided a wake-up call for the evidence community. J Clin Epidemiol. 2022 doi: 10.1016/j.jclinepi.2022.10.002. - DOI - PubMed
1. Haynes B. Can it work? Does it work? Is it worth it? The testing of healthcare interventions is evolving. BMJ. 1999;319:652–653. - PMC - PubMed
1. Deeks J.J., Dinnes J., D'Amico R., et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:1–173. - PubMed
1. Hernán M.A., Sauer B.C., Hernández-Díaz S., Platt R., Shrier I. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses. J Clin Epidemiol. 2016;79:70–75. - PMC - PubMed